Drug Shortage Report for ADENOSINE INJECTION
Report ID | 29048 |
Drug Identification Number | 02267659 |
Brand name | ADENOSINE INJECTION |
Common or Proper name | Adenosine Injection |
Company Name | FRESENIUS KABI CANADA LTD |
Market Status | MARKETED |
Active Ingredient(s) | ADENOSINE |
Strength(s) | 3MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS |
Packaging size | 3mg/mL 2mL |
ATC code | C01EB |
ATC description | OTHER CARDIAC PREPARATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-11-10 |
Estimated end date | 2018-01-05 |
Actual end date | 2017-12-21 |
Shortage status | Resolved |
Updated date | 2018-02-01 |
Company comments | Product on backorder, code K051002 Adenosine 3mg/mL 2mL Prefilled Syringe available for substitution. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2018-02-01 | French | Compare |
v10 | 2018-02-01 | English | Compare |
v9 | 2018-02-01 | English | Compare |
v8 | 2018-02-01 | English | Compare |
v7 | 2018-02-01 | English | Compare |
v6 | 2018-02-01 | English | Compare |
v5 | 2017-12-22 | French | Compare |
v4 | 2017-12-22 | English | Compare |
v3 | 2017-11-13 | French | Compare |
v2 | 2017-11-13 | French | Compare |
v1 | 2017-11-13 | English | Compare |
Showing 1 to 11 of 11